Back to Wyoming

HB0152 • 2025

Donated blood-mRNA disclosure.

AN ACT relating to public health and safety; requiring blood donors to disclose vaccination status as specified; requiring blood packaging to be marked as specified; allowing a person who receives a blood transfusion to request the use of certain blood; providing definitions; requiring rulemaking; and providing for an effective date.

Did Not Pass

The latest official action shows that this bill did not move forward in that session.

Sponsor
Representative McCann
Last action
2025-02-03
Official status
inactive
Effective date
3/1/2025

Plain English Breakdown

The bill did not pass and was not considered for introduction, so its provisions are not in effect.

Blood Donation and Vaccination Disclosure

The bill requires blood donors to disclose if they have received a COVID-19 or mRNA vaccine, marks the donated blood accordingly, allows recipients to request specific types of blood in nonemergency situations, and sets rules for implementation.

What This Bill Does

  • Requires blood donors to tell if they've had a COVID-19 or mRNA vaccine.
  • Marks donated blood packages if it came from someone who got a COVID-19 or mRNA vaccine.
  • Gives people getting blood transfusions the right to ask for specific types of blood in nonemergency situations, if available.

Who It Names or Affects

  • Blood donors
  • People receiving blood transfusions
  • Health care providers and facilities

Terms To Know

mRNA vaccine
A type of vaccine that uses messenger ribonucleic acid to produce an immune response against a disease.
Conspicuously marked
Clearly labeled or easily seen

Limits and Unknowns

  • The bill did not pass and was not considered for introduction.
  • It is unclear how this would affect blood supply availability.

Bill History

  1. 2025-02-03 House

    H Did not Consider for Introduction

  2. 2025-01-14 House

    H Received for Introduction

  3. 2025-01-13 LSO

    Bill Number Assigned

Current Bill Text

Read the full stored bill text
25LSO-0376
2025
STATE OF WYOMING
25LSO-0376
Numbered
2.0

HOUSE BILL NO. HB0152

Donated blood-mRNA disclosure.

Sponsored by: Representative(s) McCann, Allemand, Angelos, Heiner, Locke, Ottman, Pendergraft, Rodriguez-Williams, Smith, S, Styvar and Wasserburger and Senator(s) Hutchings, Pearson and Steinmetz

A BILL

for

AN ACT relating to public health and safety; requiring blood donors to disclose vaccination status as specified; requiring blood packaging to be marked as specified; allowing a person who receives a blood transfusion to request the use of certain blood; providing definitions; requiring rulemaking; and providing for an effective date.

Be It Enacted by the Legislature of the State of Wyoming:

Section 1
.

W.S. 35
‑
4
‑
1101 is created to read:

ARTICLE 11
BLOOD DONATIONS AND VACCINATIONS

35
‑
4
‑
1101.

Disclosure of mRNA vaccinations for blood donations; labeling; right to request certain blood; definitions.

(a)

As used in this chapter:

(i)

"COVID
‑
19" means as defined in W.S. 1
‑
1
‑
141(a)(ii);

(ii)

"Messenger ribonucleic acid vaccine" means a type of vaccine that uses called messenger ribonucleic acid to produce an immune response against a disease.

(b)

Any person who collects human blood donations for the purpose of providing blood for human blood transfusion shall require blood donors to disclose whether the blood donor has received a COVID
‑
19 vaccine or a messenger ribonucleic acid vaccine at any time.

(c)

Blood originating from a donor who has received a COVID
‑
19 vaccine or a messenger ribonucleic acid vaccine shall be conspicuously marked on the packaging of the blood and any paperwork related to the blood.

(d)

In a nonemergency situation, as determined by the health care provider providing medical services, a person receiving a blood transfusion shall have the right to request blood based on whether or not the blood originated from a person who has received a COVID
‑
19 vaccine or a messenger ribonucleic acid vaccine, if the requested blood is available at the facility.

Section 2
.

The department of health shall promulgate all rules necessary to implement this act.

Section 3
.

This act is effective July 1, 2025
.

(END)

1
HB0152